InvestorsHub Logo
Post# of 216694
Next 10
Followers 12
Posts 157
Boards Moderated 1
Alias Born 09/04/2013

Re: None

Wednesday, 12/10/2014 12:39:08 PM

Wednesday, December 10, 2014 12:39:08 PM

Post# of 216694
ORGS trending..jumped to .70 earlier..breakthough diabetes cure...If you look at the longer term chart, this stock as been steadily rebuilding off of .50 following a dramatic runup in Oct to a buck following patent news..
Orgenesis Inc. (ORGS)-Other OTC
0.65 Up 0.05(8.33%) 11:20AM EST



Orgenesis Approved for EUR 2.015.000 Grant to Support Development of Its Type 1 Diabetes Program in EuropeMarketwired(Mon, Nov 24)
How Orgenesis Hopes To Cure Type 1 DiabetesBenzinga(Mon, Nov 3)
Orgenesis Receives Patent for Potential Cure for Type 1 DiabetesMarketwired(Wed, Oct 15)Note: Greenbackers will be profiling ORGS to our greater databases tomorrow pre mkt.
CYRN deal sounds pretty significant.....Dips near 2.30 looking to reward near term




Patent Award for Diabetes Cure
By Tobin Smith | December 9, 2014, 5:06pm GMT
Orgenesis (ORGS) is a public company committed to curing type 1 diabetes with a breakthrough technology that combines cellular therapy and regenerative medicine – “Cellular Transdifferentiation.”

Professor Sarah Ferber and the research team at Orgenesis have successfully reprogrammedliver cells into fully functional Insulin Producing Cells (IPCs). They’ve had success curing diabetes in mice, and begin Phase 1 clinical trials in Type 1 diabetic patients in the next 12-15 months.

Unlike other diabetic treatments, the Orgenesis procedure is a cure for diabetics requiring insulin injections to regulate glucose in their blood stream.

Read the entire article here

http://asweetlife.org/feature/orgenesis-receives-new-patent-for-potential-t1d-cure/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.